1. Home
  2. PGEN vs FIVN Comparison

PGEN vs FIVN Comparison

Compare PGEN & FIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$7.13

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Five9 Inc.

FIVN

Five9 Inc.

HOLD

Current Price

$32.90

Market Cap

2.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
FIVN
Founded
1998
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.2B
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
PGEN
FIVN
Price
$7.13
$32.90
Analyst Decision
Buy
Buy
Analyst Count
5
18
Target Price
$8.33
$26.06
AVG Volume (30 Days)
6.0M
3.4M
Earning Date
05-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
364.71
EPS
0.03
0.25
Revenue
$230,981,000.00
$1,149,088,000.00
Revenue This Year
$1,115.92
$11.39
Revenue Next Year
$81.04
$10.00
P/E Ratio
$248.00
$129.20
Revenue Growth
N/A
10.28
52 Week Low
$2.99
$13.29
52 Week High
$7.49
$34.58

Technical Indicators

Market Signals
Indicator
PGEN
FIVN
Relative Strength Index (RSI) 62.70 61.21
Support Level $3.96 $17.59
Resistance Level $7.32 $34.58
Average True Range (ATR) 0.44 2.01
MACD 0.02 -0.10
Stochastic Oscillator 75.70 73.51

Price Performance

Historical Comparison
PGEN
FIVN

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About FIVN Five9 Inc.

Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.

Share on Social Networks: